Cargando…
Network pharmacology-based and experimental identification of the effects of Renshen Yangrong decoction on myocardial infarction
Objective: Myocardial infarction (MI) is one of the leading causes of death worldwide. Currently, the drugs used to treat MI have various side effects. Emerging evidence supports the protective effects of Renshen Yangrong Decoction (RSYRD) in cardiovascular diseases (CVDs) treatments, with few side...
Autores principales: | Zhao, Jiahao, Xu, Xing, Yang, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641366/ https://www.ncbi.nlm.nih.gov/pubmed/36386237 http://dx.doi.org/10.3389/fphar.2022.1010036 |
Ejemplares similares
-
Clinical and Basic Research on Renshen Yangrong Decoction
por: Sheng, Wei, et al.
Publicado: (2019) -
Modified Renshen Yangrong decoction enhances angiogenesis in ischemic stroke through promotion of MicroRNA‐210 expression by regulating the HIF/VEGF/Notch signaling pathway
por: Liang, Ce, et al.
Publicado: (2021) -
The mechanism of Renshen-Fuzi herb pair for treating heart failure—Integrating a cardiovascular pharmacological assessment with serum metabolomics
por: Chen, Xiaofei, et al.
Publicado: (2022) -
Modified Renshen Wumei Decoction Alleviates Intestinal Barrier Destruction in Rats with Diarrhea
por: Guan, Zhiwei, et al.
Publicado: (2021) -
Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
por: Yang, Yingying, et al.
Publicado: (2021)